SAN ANTONIO (Aug. 17, 2020) — The list of accomplishments and data supporting the renewal of the Mays Cancer Center as a National Cancer Institute-designated Cancer Center is impressive. 71% increase in peer-reviewed publications. 60% jump in research funding. Significant recruitment of women and Hispanics into cancer clinical trials. 60 new scientists recruited. $20.6 million renovation […]
A team of researchers from UT Health San Antonio and UT Southwestern have published a study in the Journal of Cancer Education showing that a new, shortened training program for health care providers may increase screenings for hepatitis C virus (HCV) across the region.
San Antonio site was largest in the world for second study involving baricitinib SAN ANTONIO (Aug. 7, 2020) — UT Health San Antonio, with its clinical partner University Health System, are among the first study sites in the nation to begin the third phase of the COVID-19 clinical trial involving remdesivir. The Adaptive COVID-19 Treatment […]
UT Health San Antonio and its clinical partner University Health System are on the front lines working to find new treatments for COVID-19.
Ruben Mesa, MD, FACP, has been elected an officer on the national board of the Leukemia & Lymphoma Society.
SAN ANTONIO (July 31, 2020) — Ruben Mesa, M.D., FACP, has been elected an officer on the national board of the Leukemia & Lymphoma Society. Dr. Mesa is director of the Mays Cancer Center, home to UT Health San Antonio MD Anderson, where he holds the Mays Family Foundation Distinguished University Presidential Chair. The Mays […]